# Nautilus Biotechnology, Inc.: Form 8-K, filed Feb 28, 2024

- Company: [Nautilus Biotechnology, Inc.](/companies/naut.md) (CIK 1808805)
- Form: 8-K
- Filed: 2024-02-28
- Accepted by EDGAR: Feb 28, 2024, 07:26 ET
- Period: 2024-02-28
- Accession: 0001628280-24-007395
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1808805/000162828024007395/naut-20240228.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1808805/000162828024007395/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1808805/000162828024007395/naut-20240228.htm

Filed Feb 28, 2024.
Source: SEC EDGAR, the filing index for accession 0001628280-24-007395. Last ingested by Listed: Nov 3, 2026, 18:40 ET. No prices; not investment advice.